Pnömonili Hastaya Yaklaşım

Authors

Jihat Kılıç

Synopsis

Pneumonia is the 7th leading cause of death worldwide, developing due to the infection of the lung parenchyma and disruption of the microbiota balance. Its most common classic presentation includes the triad of fever, cough, and pulmonary infiltrates. Typical (S. pneumoniae) and atypical bacteria, along with respiratory viruses, predominate in its etiology. The first and most critical step in management is determining the need for hospitalization using scoring systems such as PSI or CURB-65. While outpatient cases are treated with Amoxicillin, Macrolides, or Doxycycline, hospitalized and intensive care unit patients are managed with anti-pseudomonal beta-lactams and supplemental agents based on the risk of MRSA and Pseudomonas. Glucocorticoid therapy may be added in cases with a severe inflammatory response or vasopressor resistance. In COVID-19 pneumonia, Dexamethasone and Remdesivir stand out alongside supportive care. Clinical and laboratory findings, rather than radiological imaging, should be prioritized for follow-up and discharge decisions, as lung lesions may take weeks to resolve on chest X-rays. Rational antibiotic use is essential to prevent resistance, especially considering that symptoms may present atypically in elderly and immunosuppressed patients.

References

Ashar B.H, Miller R.G, Sissan S.D. John Hopkins Internal Medicine Board Review 5. Edition Paul G. Auwaerter Respiratory infections 83-7

Vashisht R, Yilmaz G, Bhardwaj A. Pubmed Jain Pneumonia Pathology. Erişim linki: https://www.ncbi.nlm.nih.gov/books/NBK526116/

Ramirez J. A File T, M Jr, Bond S. Uptodate FACP Overview of community-acquired pneumonia in adults. Erişim linki: https://www.uptodate.com/contents/overview-of-community-acquired-pneumonia-in-adults.

Klompas M., MD, Ramirez J. A. MD, Bond, S. MPH Clinical evaluation and diagnostic testing for community-acquired pneumonia in adults https://www.uptodate.com/contents/clinical-evaluation-and-diagnostic-testing-for-community-acquired-pneumonia-in-adults Feb 01, 2021.

Patel S, Veltri K. Antimicrobial Therapy for Community-Acquired Pneumonia US Pharm. 2015;40 (4):HS9-HS13. Erişim linki: https://www.uspharmacist.com/article/antimicrobial-therapy-for-communityacquired-pneumonia

File TM Jr, Niederman MS. Treatment of community-acquired pneumonia in adults who require hospitalization. Uptodate. Erişim linki: https://www.uptodate.com/contents/treatment-of-community-acquired-pneumonia-in-adults-who-require-hospitalization

Alici İO, Çapan N, Ertürk A, Canbakan S. Comparison of Severity Scoring Systems in Community-Acquired Pneumonia. Solunum. 2015; 17(1): 15 - 21.

Non L.R., Patel R.R. Community-acquired Pneumonia Kollef M.H, Isakow W, Burks A.C, Despotovic V.(edt) The Washington Manual of Critical Care 3rd edition 334-6

Kim YA, Gandhi RT, Hirsch SM, Bloom A. FIDSA Uptodate Coronavirus disease 2019 (COVID-19): Management in hospitalized adults Erişim linki:https://www.uptodate.com/contents/coronavirus-disease-2019-covid-19-management-in-hospitalized-adults

Published

May 20, 2021

License

License